Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for refractory myasthenia gravis
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal long-term use of proton pump inhibitors]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Aflibercept (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Voke 0.45mg inhaler for smoking cessation – first line
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Magnetic resonance spectroscopy and magnetic resonance imaging with tractography for psychiatric disorders
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Rectal cancer investigation, treatment and follow-up algorithm]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Regorafenib - Addendum to Commission A15-43]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Crisaborole for adults, adolescents and children with atopic dermatitis
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Prostate bipolar transurethral resection for the treatment of benign prostatic hyperplasia
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Colon cancer investigation, treatment and follow-up algorithm (update)]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Netarsudil for open-angle glaucoma or ocular hypertension
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Eculizumab in nocturnal paroxysmal hemoglobinuria and atypical hemolytic-uremic syndrome
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Feasibility and appropriateness of implementing satellite radiotherapy centres equipped with a single linear accelerator]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Lumacaftor/ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Health Technology Assessment programme	The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Mitomycin ophthalmic (Mitosol) for glaucoma surgery
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Augmentative and alternative communication device with eye tracking (TOBII) in language and motor speech disorders
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Evidence brief on the measures related to the reimbursement of blood glucose test strips]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "rheumatoid arthritis"]
2016	NIHR Health Services and Delivery Research programme	Improving skills and care standards in the support workforce for older people: a realist synthesis of workforce development interventions
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Enzyme replacement therapy in Gaucher Disease
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Effect of palivizumab prophylaxis in reducing the complications associated with the respiratory syncytial virus in infants and young children]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Secukinumab (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Health Services and Delivery Research programme	Integrated care to address the physical health needs of people with severe mental illness: a rapid review
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Sacubitril in combination with valsartan for chronic heart failure
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cobimetinib - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	An enhanced recovery after surgery program for hip and knee arthroplasty
2016	NIHR Health Technology Assessment programme	Modelling disease progression in relapsing remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort
2016	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Endoscopic radiofrequency ablation in gastroesophageal reflux disease
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Circulating tumour cells in breast cancer: clinical use of the CellSearch® test]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Efmoroctocog alfa - Benefit assessment according to § 35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	LINX reflux management system
2016	Agency for Healthcare Research and Quality (AHRQ)	Diabetes medications for adults with type 2 diabetes: an update
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Ultrasound of peripheral nerves
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Rilpivirine (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Cryotherapy, radioablation and irreversible electroporation for prostate cancer
2016	Agency for Healthcare Research and Quality (AHRQ)	Imaging for the pretreatment staging of small cell lung cancer
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Positron emission tomography/magnetic resonance imaging (PET/MRI) in cancer
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vemurafenib for the treatment of pediatric patients with braf v600e mutation-positive ganglioglioma]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Crizotinib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	CT to reduce negative appendectomy rates
2016	Belgian Health Care Knowledge Centre (KCE)	Left ventricular assist devices in the treatment of end-stage heart failure
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Ultrasound-guided sclerotherapy with foam in chronic vein insufficiency
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Clinical guides in antibiotic treatment – 1st series (update)]
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	[Bariatric surgery to treat obesity with a body mass index (BMI) less than 40 kg/m2]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sacubitril/valsartan - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Retrograde endovascular balloon occlusion of the aorta (REBOA)
2016	NIHR Health Technology Assessment programme	UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Anti-mog (myelin oligodendrocyte glycoprotein) antibodies for the diagnosis of optic neuromyelitis and other demyelinating diseases
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Economic evaluation of the molecular diagnosis of the influenza virus]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	MicroVisualase Thermal Therapy System: MRI-guided laser ablation of neurologic tumourswave ablation for liver tumours
2016	NIHR Public Health Research (PHR) programme	Interventions to promote or maintain physical activity during and after the transition to retirement: an evidence synthesis
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	[Alemtuzumab for multiple sclerosis]
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Evaluation of subcutaneous-lead implantable cardioverter-defibrillators]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "osteoporosis"]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Health Policy Advisory Committee on Technology (HealthPACT)
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Brentuximab vedotin in lymphomas
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of radioactive seeds for the preoperative localization of non-palpable breast tumours]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Hyperbaric oxygen therapy for diabetic foot syndrome]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Radiofrequency ablation for treating nasal hypertrophy of the inferior turbinates
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Endoscopic radiofrequency ablation (Secca Procedure) for the treatment of fecal incontinence
2016	HAYES, Inc.	Balloon sinuplasty for treatment of chronic rhinosinusitis
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Alirocumab - Addendum to Commission A15-47]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SureFire Precision Chemoembolization Infusion system keeps drugs within liver tumours
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Elastomeric drug infusion pumps
2016	HAYES, Inc.	Comparative effectiveness of bivalirudin versus heparin monotherapy for percutaneous coronary intervention (PCI)
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Umeclidinium - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Argus II Retinal prosthesis
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Autoantibody panel for autoimmune encephalitis
2016	HAYES, Inc.	Electrical bone growth stimulation, invasive
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Mepolizumab - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	BioZorb - an implantable device to delimit surgical site after lumpectomy in breast cancer
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	BAHA® bone-anchored hearing aid for the treatment of hearing loss
2016	HAYES, Inc.	High-frequency chest wall compression for diseases other than cystic fibrosis
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ibrutinib - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Wireless technology for LV pacing without coronary sinus
2016	NIHR Health Technology Assessment programme	Automated imaging technologies for the diagnosis of glaucoma: a comparative diagnostic study for the evaluation of the diagnostic accuracy, performance as triage tests and cost-effectiveness (GATE study)
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Mutational screening of notch3 gene in the diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukocencephalopathy (CADASIL)
2016	HAYES, Inc.	Hyperbaric oxygen therapy for sudden sensorineural hearing loss
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Fingolimod (new therapeutic indication) - Addendum to Commission A15-48]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Non-invasive open ventilation system
2016	NIHR Health Technology Assessment programme	The feasibility of determining the effectiveness and cost-effectiveness of medication organisation devices compared with usual care for older people in a community setting: systematic review, stakeholder focus groups and feasibility randomised controlled trial
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Radioembolization and chemoembolization with drug-eluting microspheres for the treatment of liver tumors
2016	HAYES, Inc.	Indwelling pleural catheters for the management of malignant pleural effusions
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Parent information on newborn screening using pulse oximetry; addendum to commission S13-01]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Ovation iX Abdominal Stent Graft System
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss
2016	HAYES, Inc.	Minimally invasive surgical (MIS) procedures for treatment of atrial fibrillation
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Implementation of guidelines - obstructive and beneficial factors]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Bioresorbable stents
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Hydrophobic acrylic intraocular lenses in cataract surgery due to uveitis
2016	HAYES, Inc.	Minimally invasive transforaminal lumbar interbody fusion (mitlif) versus open transforaminal lumbar interbody fusion (otlif) for treatment of lumbar disc disease: a review of reviews
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Afamelanotide - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]